Basilea Pharmaceutica AG

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Basilea Pharmaceutica AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 11.46% vs 32.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -48.20% vs 639.05% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "232.40",
          "val2": "208.50",
          "chgp": "11.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "55.30",
          "val2": "64.70",
          "chgp": "-14.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.40",
          "val2": "4.30",
          "chgp": "-20.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.20",
          "val2": "77.60",
          "chgp": "-48.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "221.80%",
          "val2": "293.40%",
          "chgp": "-7.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

232.40

208.50

11.46%

Operating Profit (PBDIT) excl Other Income

55.30

64.70

-14.53%

Interest

3.40

4.30

-20.93%

Exceptional Items

0.00

0.00

Consolidate Net Profit

40.20

77.60

-48.20%

Operating Profit Margin (Excl OI)

221.80%

293.40%

-7.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 11.46% vs 32.30% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -48.20% vs 639.05% in Dec 2024

All Annual Results